Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Therapeutic targeting of G protein-coupled receptors in central nervous system disorders: from novel mechanisms to precision pharmacology.
Galectins as stress-integrating regulators of neuroimmune signaling and proteinopathy in the central nervous system.
A pipeline to characterize spinal cord pathology in neurological disorders combining magnetic resonance microscopy and histopathology.
Understanding the Unmet Needs of People with MS at Diagnosis and Throughout Their Care Journey: Insights from a Survey-Based Study.
Correction: Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.
[Criteria for choosing treatment of multiple sclerosis].
Proteomic Signatures of Protected -ε4 Carriers Reveal Causal Pathways Associated with Delayed Alzheimer's Disease Onset.
Risk of non-infectious uveitis associated with disease-modifying therapies for multiple sclerosis.
Multiple Sclerosis and Outpatient Physician Care in the Last Years of Life: A Population-Based Study.
Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.
Artificial intelligence and machine learning in neurogenic lower urinary tract dysfunction and spinal cord injury: current status, emerging technologies, and ethical perspectives.
Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.
Kv1.3 Channel Blockade by Dalfampridine Attenuates NLRP3 Inflammasome-Driven Demyelination via the NEK7/Ripk1/FADD Pathway, Matching the Efficacy of Broad P2X7 Antagonism by Suramin in EAE.
Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis.
Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis.
Eosinophil Recruitment and Activity in CNS Lesions of MOG Antibody-Associated Myelitis Following Influenza Vaccination: A Case Report.
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot Study.
A correlation between cognitive dysfunction and employment status in multiple sclerosis - a systematic literature review.
High-efficacy therapy and progression independent of relapse and MRI activity in multiple sclerosis.
Cardiorespiratory fitness, trait anxiety, and physical activity in people with multiple sclerosis who have subclinical generalized anxiety disorder.
What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
Intraoperative contrast-enhanced ultrasound features of progressive multifocal leukoencephalopathy: a case report.
MOG-IgG-associated encephalitis and bronchopneumonia in a child with negative infection screening: a case report and literature review.
Anti-JCV antibody seroprevalence and testing practices in multiple sclerosis patients considered for natalizumab therapy: a retrospective study from King Saud Medical City, Riyadh, Saudi Arabia.
Upper Cervical Cord Area as a Biomarker of Conversion to Secondary Progressive Multiple Sclerosis.

Pages